Jain Rita

CIK 00017077979 companiesWAYNE, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001707797

Recent Transactions

50 trades

Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-06-30$15.04/sh+1,080→ 1,080 total
Award
Celldex Therapeutics, Inc.$CLDX
Non-Qualified Stock Option (right to buy)
2026-06-25+26,000→ 26,000 total
Exercise/Conversion
First Tracks Biotherapeutics, Inc.$TRAX
Restricted Stock Unit
2026-06-15−1,300→ 0 total
Exercise/Conversion
First Tracks Biotherapeutics, Inc.$TRAX
Common Stock
2026-06-15+7,330→ 19,194 total
Exercise/Conversion
First Tracks Biotherapeutics, Inc.$TRAX
Restricted Stock Unit
2026-06-15−6,030→ 0 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-06-02+20,100→ 20,100 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Stock Option (right to buy)
2026-05-12+7,000→ 7,000 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Stock Option (right to buy)
2026-05-12+42,000→ 42,000 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Restricted Stock Unit
2026-05-12+15,000→ 15,000 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Restricted Stock Unit
2026-05-12+2,500→ 2,500 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Restricted Stock Unit
2026-04-20+1,300→ 1,300 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Restricted Stock Unit
2026-04-20+4,000→ 4,000 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Restricted Stock Unit
2026-04-20+6,030→ 6,030 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Stock Option (right to buy)
2026-04-20+5,500→ 5,500 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Stock Option (right to buy)
2026-04-20+16,510→ 16,510 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Stock Option (right to buy)
2026-04-20+16,510→ 16,510 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Stock Option (right to buy)
2026-04-20+8,015→ 8,015 total
Award
First Tracks Biotherapeutics, Inc.$TRAX
Stock Option (right to buy)
2026-04-20+10,600→ 10,600 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-03-31$12.13/sh+1,339→ 1,339 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2026-01-06+5,500→ 5,500 total
Award
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2026-01-06+4,000→ 4,000 total
Award
SAB Biotherapeutics, Inc.$SABS
Stock Option (right to buy)
2026-01-05+240,000→ 240,000 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2025-12-31$14.74/sh+1,043→ 1,043 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2025-09-30+1,572→ 1,572 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2025-06-17+40,200→ 40,200 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2025-06-15−6,030→ 0 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2025-06-15−1,300→ 1,300 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2025-06-15+7,330→ 11,864 total
Award
Celldex Therapeutics, Inc.$CLDX
Non-Qualified Stock Option (right to buy)
2025-06-05+16,500→ 16,500 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2025-01-07+16,510→ 16,510 total
Award
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2025-01-07+6,030→ 6,030 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2024-06-15+4,534→ 4,534 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2024-06-15−3,234→ 0 total
Exercise/Conversion
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2024-06-15−1,300→ 0 total
Award
Celldex Therapeutics, Inc.$CLDX
Non-Qualified Stock Option (right to buy)
2024-06-13+16,500→ 16,500 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2024-01-03+16,510→ 16,510 total
Award
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2024-01-03+6,030→ 6,030 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−66,000→ 0 total
Award
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2023-04-03+3,900→ 3,900 total
Award
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2023-04-03+3,234→ 3,234 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2023-04-03+10,600→ 10,600 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2023-04-03+8,015→ 8,015 total
Award
Celldex Therapeutics, Inc.$CLDX
Non-Qualified Stock Option (right to buy)
2023-02-16+17,100→ 17,100 total
Award
Provention Bio, Inc.
Stock Option (right to buy)
2023-01-03+66,000→ 66,000 total
Disposition to Issuer
ChemoCentryx, Inc.
Common Stock
2022-10-20−35,863→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Stock Option
2022-10-20−12,287→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Stock Option
2022-10-20−23,948→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Stock Option
2022-10-20−307→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Stock Option
2022-10-20−21,052→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Restricted Stock Unit
2022-10-20−11,600→ 0 total

Companies

Recent Filings

Address

C/O AVALO THERAPEUTICS, INC. 1500 LIBERTY RIDGE DRIVE, SUITE 321

WAYNE, PA, 19087

View on SEC.gov